Mountain Valley MD Executes Soluvec™ 1% License Agreement, Expands Patent Protection
08 mai 2023 09h15 HE
|
Mountain Valley MD Holdings Inc.
TORONTO, May 08, 2023 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to announce that Mountain Valley MD Inc....
Mountain Valley MD Announces Stock Option Grant
06 mars 2023 20h10 HE
|
Mountain Valley MD Holdings Inc.
TORONTO, March 06, 2023 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP), an early-stage biotech business centered around the...
Mountain Valley MD Announces Transition of Chief Medical Officer to Advisory Role
11 janv. 2023 23h32 HE
|
Mountain Valley MD Holdings Inc.
TORONTO, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP), an early-stage biotech business centered around the...
Mountain Valley MD Provides Notice of Redemption for Class “B” Non-Voting Shares. Common Shares Trading on CSE Unaffected
07 déc. 2022 20h00 HE
|
Mountain Valley MD Holdings Inc.
TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) announces that it will redeem all issued and outstanding...
Mountain Valley MD Provides Business Update, Focus On Commercialization Phase
29 nov. 2022 09h00 HE
|
Mountain Valley MD Holdings Inc.
TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to provide a business update and details of...
Mountain Valley MD Commences Commercial Sales of Agrarius, an Agro Plant Technology
13 sept. 2022 09h00 HE
|
Mountain Valley MD Holdings Inc.
TORONTO, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to announce the commencement of commercial...
Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec™1%
27 juin 2022 09h00 HE
|
Mountain Valley MD Holdings Inc.
TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to announce the successful completion of its...
Mountain Valley MD Holdings Provides Business Update
28 avr. 2022 08h55 HE
|
Mountain Valley MD Holdings Inc.
TORONTO, April 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to provide a business update on its...
Mountain Valley MD Holdings Appoints Dr. Elizabeth Norton to Advisory Role to Support Key Quicksome™ Vaccine and Cold Chain Projects
16 mars 2022 09h00 HE
|
Mountain Valley MD Holdings Inc.
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to announce the appointment of Dr. Elizabeth...
Mountain Valley MD Holdings Announces Restricted Share Unit Plan, RSU Grant and Stock Option Grant
28 janv. 2022 21h36 HE
|
Mountain Valley MD Holdings Inc.
TORONTO, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) announces the adoption of a restricted share unit plan...